International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Use the multiple myeloma response criteria when determining the disease status for multiple myeloma and solitary plasmacytoma. Some people with multiple myeloma, especially those with. The nccn panel strongly recommends enrolling eligible smoldering myeloma patients with highrisk.
Myeloma most often grows in the marrow within the bones of the spine, skull, pelvis, rib cage, shoulders, and hips. Updates on diagnostic criteria and management of multiple myeloma. Crab is the acronym for the most common symptoms of multiple myeloma. International myeloma working group imwg updated the diagnostic criteria for mm to add three specific biomarkers that can be used to diagnose the disease. Common manifestations include lytic lesions in bones causing pain. Lateral skull radiograph showing typical multiple small punched out lesions of multiple myeloma. Multiple myeloma is a type of blood cancer that affects the bone marrow, the bodys bloodforming system.
The calculator for multiple myeloma diagnostic criteria uses parameters to make a diagnosis. Multiple myeloma accounts for around 1% of all cancers worldwide and 1015% of all hematological neoplasms. New criteria for diagnosing multiple myeloma mayo clinic. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Note, the second bullet point above was previously available in this section as a footnote. In this disease, the plasma cells a type of white blood cell become abnormal and multiply rapidly. The updated criteria for the diagnosis of myeloma represent a paradigm shift in the approach to myeloma and have considerable impact on the management of the disease. These new criteria add myeloma defining events, the presence of any one of which is sufficient to diagnose multiple myeloma. Note, the second bullet point above was previously available in this section as a. Diagnosing multiple myeloma includes blood work, a 24hour urine collection, a bone marrow biopsy, imaging studies such as xrays, mris, pet scans and bone density tests. The updated criteria, published in the lancet oncology represent a significant change in how multiple myeloma is diagnosed and the stage at which patients should be treated. Theses recommendations are excerpted from palumbo a et.
Updates on diagnostic criteria and management of multiple. Institut universitaire du cancer toulouse, france mrd metaanalysis in. The international myeloma working group imwg has updated the criteria for diagnosing multiple myeloma and published the new criteria in the lancet oncology. Multiple myeloma response criteria forms instruction. These patients typically fulfill the diagnostic criteria for multiple myeloma and have evidence of al deposition confirmed by congo red staining. Myelomaassociated amyloid lightchain al amyloidosis is reported in 12% to 30% of multiple myeloma patients. The jerome lipper multiple myeloma center and lebow institute for myeloma therapeutics provides comprehensive care to patients with multiple myeloma, including promising.
Updated diagnostic criteria and staging system for multiple. Multiple myeloma genetic and rare diseases information. Diagnostic criteria for multiple myeloma presence of an mcomponent a in serum andor urine plus clonal plasma cells in the bone marrow andor a documented clonal plasmacytoma. There has been remarkable progress made in the diagnosis and treatment of multiple myeloma mm. Malat1 long noncoding rna is overexpressed in multiple.
International myeloma working group diagnostic criteria and classification for. Feb 28, 2018 important research into multiple myeloma is being done in university hospitals, medical centers, and other institutions around the world. Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell leukemia. Multiple myeloma prognosis riss revised international staging system for myeloma cllipi the international prognostic index for patients with chronic lymphocytic leukemia expected spleen size. The imwg has established definitions of multiple myeloma and smoldering multiple myeloma. In this disease, the plasma cells a type of white blood cell become abnormal and multiply. Anderson, md danafarber cancer institute disclosure of relevant financial relationships all faculty and activity planners participating in nccn continuing education activities are expected to. The jerome lipper multiple myeloma center and lebow institute for myeloma therapeutics provides comprehensive care to patients with multiple myeloma, including promising new therapies through clinical trials rooted in an approach that brings laboratory discoveries quickly to the clinical setting. The diagnosis of active multiple myeloma requires the presence of endorgan damage. Dec 23, 2019 international myeloma working group diagnostic criteria.
Currently patients without the conventional crab criteria but with one of the biomarkers of malignancy will be excluded from trials that have not amended the entry criteria to include the new imwg. The diagnostic criteria, disease status and response to treatment were based on the criteria of the international myeloma working group 1719. Institut universitaire du cancer toulouse, france mrd metaanalysis in myeloma nikhil munshi, md lipper myeloma center danafarber cancer institute. This can cause a variety of symptoms, including excessive thirst, nausea, constipation, loss of appetite, and confusion. First described in 1848, mm is characterized by a proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein m protein. The pathogenesis of multiple myeloma involves complex genetic and epigenetic events. Diagnostic criteria of multiple myeloma sciencedirect. The participants in the united states with a confirmed diagnosis of relapsed multiple myeloma following 1 to 3 prior lines of therapy who initiate treatment with a proteasome inhibitor pi andor. Imwg criteria for the diagnosis of myeloma and guidelines for the diagnostic workup of myeloma criteria for a diagnosis of myeloma followed by the examinations, tests, and imaging studies that are recommended by the working group for the diagnosis of myeloma and related organ dysfunction. These patients typically fulfill the diagnostic criteria for multiple myeloma and have evidence. Minimal residual disease assessment in multiple myeloma by. Multiple myeloma epidemiology 2nd most common hematologic cancer in us 10%, 14,000 cases anually, 1% of cancers, 2% of cancer deaths.
Researchers have found that bone marrowsupport tissues and bone cells produce. Myeloma associated amyloid lightchain al amyloidosis is reported in 12% to 30% of multiple myeloma patients. Unlike other malignancies that metastasize to bone, the osteolytic bone lesions in multiple myeloma exhibit no new bone formation 7. Imwg criteria for the diagnosis of myeloma and guidelines for the. Role of 18ffdg petct in the diagnosis and management of multiple myeloma and other plasma cell disorders. Myeloma attacks bone, and as bone is broken down, it causes high calcium levels in the blood. Multiple myeloma response criteria forms instruction manual 1. International myeloma working group imwg criteria for the diagnosis of multiple myeloma.
New diagnostic criteria for myeloma nssg haematology. Imwg recommends taking a detailed medical history and a physical examination, routine laboratory testing complete blood count, chemical analysis, serum and. Important research into multiple myeloma is being done in university hospitals, medical centers, and other institutions around the world. Monoclonal serum protein in 787 mayo clinic patients 1990. Criteria for the classification of monoclonal gammopathies, multiple. Imwg criteria for the diagnosis of myeloma and guidelines for. In november 2014, the international myeloma working group imwg updated the criteria for the diagnosis of. Diagnosing multiple myeloma includes blood work, a 24hour urine collection, a bone marrow biopsy, imaging studies such as xrays, mris, pet scans and bone density. This study aimed to investigate the role and clinical relevance of the long noncoding rna lncrna. Multiple myeloma mm is the most common primary bone cancer. International myeloma working group imwg updated criteria for the diagnosis of multiple myeloma1 and. The parameters include plasmacytoma on tissue biopsy, bone marrow plasmacytosis, m protein, urinary kappa or lambda excretion, marrow plasmacytosis, lytic bone lesions, evidence of a monoclonal protein, and hypoglobulinemia of normal proteins.
Anderson, md danafarber cancer institute disclosure of relevant financial relationships all faculty and activity planners participating in nccn continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the accmes, anccs, and acpes standards for commercial support. Our group, which includes more than 180 myeloma researchers worldwide, has updated the definition of multiple myeloma for diagnostic purposes to include validated biomarkers in addition to the current clinical symptoms used for. Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin and invade and destroy adjacent bone tissue. Updated diagnostic criteria and staging system for. Multiple myeloma mm, also known as plasma cell myeloma is a rare malignancy of the blood originating from postgerminal center bcells and accounting for about 10% of all hematological malignancies. Each year, scientists find out more about what causes the disease and how to improve treatment. Fortyfive samples were collected from newly diagnosed patients 29 males, 16 females. In november 2014, the international myeloma working group imwg updated the criteria for the diagnosis of multiple myeloma to include novel validated biomarkers to better encompass the extent of disease. Multiple myeloma mm, also known as plasma cell myeloma is a rare malignancy of the blood originating from postgerminal center bcells and accounting for about 10% of all hematological. Mar 12, 2016 multiple myeloma is a form of cancer that occurs due to abnormal and uncontrolled growth of plasma cells in the bone marrow.
The parameters include plasmacytoma on tissue biopsy, bone marrow plasmacytosis, m protein, urinary. Bsh administrator, british society for haematology, 100 white lion street, london n1 9pf, uk. Kyle, md the diagnosis of multiple myeloma often begins with the recognition of a monoclonal protein in the serum or urine or both. Technetium99msestamibi scintigraphy in multiple myeloma and related gammopathies.
Multiple myeloma is defined as clonal bone marrow plasma cells. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders. Below are the criteria for a diagnosis of myeloma followed by the examinations, tests, and. The patients of extramedullary myeloma were not enrolled to this study. International myeloma working group diagnostic criteria. Guidelines for the use of imaging in the management of patients with myeloma andrew chantry,1, majid kazmi,2, sally barrington,3,4 vicky goh,3,5 nicola mulholland,6 matthew streetly,2 maggie lai7, guy. Radiation oncologymultiple myeloma wikibooks, open books. Usually, the bones of the hands, feet, and lower parts of the arms and legs are not affected, preserving the function of these critical areas.
Join us on march 10th on a webinar covering these updated criteria for myeloma and related plasma cell disorders and the importance of biomarkers in early stage disease. Minimal residual disease assessment in multiple myeloma by nextgeneration sequencing prof herve avetloiseau, md, phd. This causes them to interfere with the production of normal blood cells. Nccn clinical practice guidelines in oncology nccn. Imwg criteria for the diagnosis of myeloma and guidelines for the diagnostic workup of myeloma criteria for a diagnosis of myeloma followed by the examinations, tests, and imaging studies that are. The median age of patients at the time of diagnosis is about 65 years 6.
International myeloma working group updated criteria for. Each year, scientists find out more about what causes. Multiple myeloma is a form of cancer that occurs due to abnormal and uncontrolled growth of plasma cells in the bone marrow. In germany there are around 6500 new cases of multiple myeloma each year and it is the third most commonly occurring disease of the blood after leukemia and nonhodgkin lymphoma. All patients with a suspected diagnosis of mm should undergo a basic workup, including complete blood count. The diagnostic and response criteria recommended are primarily derived from the international myeloma working group, with certain updates and clarifications. Common manifestations include lytic lesions in bones causing pain, andor fractures, renal insufficiency, hypercalcemia, anemia, and recurrent infections. Imwg criteria for the diagnosis of myeloma and guidelines. Group revised the diagnostic criteria for multiple myeloma. Multiple myeloma prognosis riss revised international staging system for myeloma cllipi the international prognostic index for patients with chronic lymphocytic leukemia expected spleen size provides upper limit of normal for spleen length and volume by ultrasound relative to body height and gender. Imwg criteria for the diagnosis of mm inl myeloma fn. Doctors are working to learn more about myeloma, ways to prevent it, how to best treat it, and how to provide the best care to people diagnosed with this disease.
The diagnostic criteria for smoldering asymptomatic multiple myeloma is a serum m protein level of 3 g per dl 30 g per l or more, 10 percent or more bone marrow plasma cells, and no related organ or tis sue impairment i. In 2014, the international myeloma working group imwg updated the diagnostic criteria for mm to add three specific biomarkers that can be used to diagnose. The participants in the united states with a confirmed diagnosis of relapsed multiple myeloma following 1 to 3 prior lines of therapy who initiate treatment with a proteasome inhibitor pi andor immunomodulatory drug imid used either as monotherapy or combination therapy with other treatments as per routine clinical practice within 90 days prior to study enrollment. Multiple myeloma mm is a clonal plasma cell malignant neoplasm that accounts for approximately 10% of hematologic malignant disorders. The median survival of the disease has doubled as a result of several new active. Presence of an mcomponent a in serum andor urine plus clonal plasma cells in the bone marrow andor a documented clonal plasmacytoma. The most common clinical diagnosis was monoclonal gammopathy of undetermined significance mgus, which occurred in 63% of patients fig. Added the bullet points below to general reporting guidelines. Some people with multiple myeloma, especially those with early stages of the condition, have no concerning signs or symptoms. You will read about the scientific research being done now to learn more about multiple myeloma and how to treat it.
353 1302 1008 818 1478 477 859 1443 1209 216 1477 1463 1122 698 32 16 380 236 1338 1490 458 1467 1456 717 934 1238 779 70 79 1035 1004 1198 1272 478 373 508 38 939 1132 993 571 877 651 1048 1314 1203 1106 769